Skip to search.
 TSX Up 1.03% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On TKM.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Tekmira Pharmaceuticals Corporation (TKM.TO)

-Toronto

4.90 Up 0.05(1.03%) 3:39PM EDT

Add to Portfolio
Prev Close:4.85
Open:4.85
Bid:4.85
Ask:4.93
1y Target Est:12.50
Beta:N/A
Next Earnings Date:N/A
Day's Range:4.85 - 4.90
52wk Range:1.92 - 6.49
Volume:4,217
Avg Vol (3m):25,848
Market Cap:70.44M
P/E (ttm):2.26
EPS (ttm):2.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
TKM.TOUp 1.03%70.44M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 2.35%11.77B
SUNPHARMA.NSUp 0.83%1.01T
GILD.MXUp 2.12%1.06T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-12) :N/A
Quarterly EPS Est (Sep-12) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback